185 related articles for article (PubMed ID: 24403021)
1. LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.
Bian EB; Li J; Xie YS; Zong G; Li J; Zhao B
J Cell Physiol; 2015 Mar; 230(3):496-503. PubMed ID: 24403021
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
[TBL] [Abstract][Full Text] [Related]
3. Functional roles of enhancer of zeste homolog 2 in gliomas.
Yin Y; Qiu S; Peng Y
Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
[TBL] [Abstract][Full Text] [Related]
4. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.
Yang A; Wang H; Yang X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PAR5 inhibits the proliferation and progression of glioma through interaction with EZH2.
Wang XP; Shan C; Deng XL; Li LY; Ma W
Oncol Rep; 2017 Nov; 38(5):3177-3186. PubMed ID: 29048683
[TBL] [Abstract][Full Text] [Related]
7. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
9. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
10. LncRNAs: the bridge linking RNA and colorectal cancer.
Yang Y; Zhao L; Lei L; Lau WB; Lau B; Yang Q; Le X; Yang H; Wang C; Luo Z; Xuan Y; Chen Y; Deng X; Xu L; Feng M; Yi T; Zhao X; Wei Y; Zhou S
Oncotarget; 2017 Feb; 8(7):12517-12532. PubMed ID: 27888635
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas.
Sun Y; Wang Z; Zhou D
Med Hypotheses; 2013 Aug; 81(2):319-21. PubMed ID: 23688743
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells.
Zhang R; Wang R; Chang H; Wu F; Liu C; Deng D; Fan W
Oncol Rep; 2012 Dec; 28(6):2278-84. PubMed ID: 22992977
[TBL] [Abstract][Full Text] [Related]
13. Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen.
Pedram Fatemi R; Salah-Uddin S; Modarresi F; Khoury N; Wahlestedt C; Faghihi MA
J Biomol Screen; 2015 Oct; 20(9):1132-41. PubMed ID: 26173710
[TBL] [Abstract][Full Text] [Related]
14. Binding interactions between long noncoding RNA HOTAIR and PRC2 proteins.
Wu L; Murat P; Matak-Vinkovic D; Murrell A; Balasubramanian S
Biochemistry; 2013 Dec; 52(52):9519-27. PubMed ID: 24320048
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINK-A promotes glioma cell growth and invasion via lactate dehydrogenase A.
Wu D; Zhao B; Cao X; Wan J
Oncol Rep; 2017 Sep; 38(3):1525-1532. PubMed ID: 28714007
[TBL] [Abstract][Full Text] [Related]
17. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression.
Zhu L; Xu PC
Biochem Biophys Res Commun; 2013 Mar; 432(4):612-7. PubMed ID: 23438432
[TBL] [Abstract][Full Text] [Related]
18. NSPc1 polycomb protein complex binds and cross‑talks to lncRNAs in glioma H4 cells.
Wang Y; Liang Z; Li H; Tao J; Sun Y; Gong Y
Oncol Rep; 2019 Apr; 41(4):2575-2584. PubMed ID: 30720120
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome.
Benetatos L; Voulgaris E; Vartholomatos G; Hatzimichael E
Int J Cancer; 2013 Jul; 133(2):267-74. PubMed ID: 23001607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
